Literature DB >> 23847814

Ecology of antimicrobial resistance: humans, animals, food and environment.

Bruno González-Zorn1, José A Escudero.   

Abstract

Antimicrobial resistance is a major health problem. After decades of research, numerous difficulties in tackling resistance have emerged, from the paucity of new antimicrobials to the inefficient contingency plans to reduce the use of antimicrobials; consequently, resistance to these drugs is out of control. Today we know that bacteria from the environment are often at the very origin of the acquired resistance determinants found in hospitals worldwide. Here we define the genetic components that flow from the environment to pathogenic bacteria and thereby confer a quantum increase in resistance levels, as resistance units (RU). Environmental bacteria as well as microbiomes from humans, animals, and food represent an infinite reservoir of RU, which are based on genes that have had, or not, a resistance function in their original bacterial hosts. This brief review presents our current knowledge of antimicrobial resistance and its consequences, with special focus on the importance of an ecologic perspective of antimicrobial resistance. This discipline encompasses the study of the relationships of entities and events in the framework of curing and preventing disease, a definition that takes into account both microbial ecology and antimicrobial resistance. Understanding the flux of RU throughout the diverse ecosystems is crucial to assess, prevent and eventually predict emerging scaffolds before they colonize health institutions. Collaborative horizontal research scenarios should be envisaged and involve all actors working with humans, animals, food and the environment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23847814     DOI: 10.2436/20.1501.01.163

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  13 in total

1.  Small-plasmid-mediated antibiotic resistance is enhanced by increases in plasmid copy number and bacterial fitness.

Authors:  Alvaro San Millan; Alfonso Santos-Lopez; Rafael Ortega-Huedo; Cristina Bernabe-Balas; Sean P Kennedy; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

2.  Klebsiella pneumoniae sequence type 11 from companion animals bearing ArmA methyltransferase, DHA-1 β-lactamase, and QnrB4.

Authors:  Laura Hidalgo; Belen Gutierrez; Cristina M Ovejero; Laura Carrilero; Stephanie Matrat; Courage K S Saba; Alfonso Santos-Lopez; Daniel Thomas-Lopez; Andreas Hoefer; Monica Suarez; Gloria Santurde; Carmen Martin-Espada; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

Review 3.  Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species.

Authors:  Chiara Devirgiliis; Paola Zinno; Giuditta Perozzi
Journal:  Front Microbiol       Date:  2013-10-08       Impact factor: 5.640

4.  Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine.

Authors:  Cristina Latasa; Maite Echeverz; Begoña García; Carmen Gil; Enrique García-Ona; Saioa Burgui; Noelia Casares; Sandra Hervás-Stubbs; Juan José Lasarte; Iñigo Lasa; Cristina Solano
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

5.  Anti-microbial coating innovations to prevent infectious diseases (AMiCI): Cost action ca15114.

Authors:  Colum P Dunne; Minna M Keinänen-Toivola; Anne Kahru; Birgit Teunissen; Hulya Olmez; Isabel Gouveia; Luis Melo; Kazimierz Murzyn; Martina Modic; Merja Ahonen; Pete Askew; Theofilos Papadopoulos; Christian Adlhart; Francy R L Crijns
Journal:  Bioengineered       Date:  2017-05-19       Impact factor: 3.269

6.  Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.

Authors:  Xiujuan Meng; Sidi Liu; Juping Duan; Xun Huang; Pengcheng Zhou; Xinrui Xiong; Ruie Gong; Ying Zhang; Yao Liu; Chenchao Fu; Chunhui Li; Anhua Wu
Journal:  BMC Infect Dis       Date:  2017-01-17       Impact factor: 3.090

7.  Proactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings: Opinion of the COST Action Network AMiCI.

Authors:  Merja Ahonen; Anne Kahru; Angela Ivask; Kaja Kasemets; Siiri Kõljalg; Paride Mantecca; Ivana Vinković Vrček; Minna M Keinänen-Toivola; Francy Crijns
Journal:  Int J Environ Res Public Health       Date:  2017-03-31       Impact factor: 3.390

8.  Development of Inducible CD19-CAR T Cells with a Tet-On System for Controlled Activity and Enhanced Clinical Safety.

Authors:  Xingjian Gu; Dongyang He; Caixin Li; Hua Wang; Guanghua Yang
Journal:  Int J Mol Sci       Date:  2018-11-03       Impact factor: 5.923

Review 9.  Escherichia coli in Europe: an overview.

Authors:  Nerino Allocati; Michele Masulli; Mikhail F Alexeyev; Carmine Di Ilio
Journal:  Int J Environ Res Public Health       Date:  2013-11-25       Impact factor: 3.390

10.  Draft Genome Sequence Analysis of Multidrug-Resistant Escherichia coli Strains Isolated in 2013 from Humans and Chickens in Nigeria.

Authors:  Poonam Sharma; Sushim K Gupta; Eyitayo O Adenipekun; John B Barrett; Lari M Hiott; Tiffanie A Woodley; Bamidele A Iwalokun; Kolawole S Oyedeji; Afolabi Oluwadun; Hazem Ramadan; Jonathan G Frye; Charlene R Jackson
Journal:  Genome Announc       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.